FDA approves new treatment for erosive esophagitis

FDA approves new treatment for erosive esophagitis

The U.S. Food and Drug Administration (FDA) has approved vonoprazan tablets 10 mg and 20 mg (Voquezna, Phathom Pharmaceuticals) for the cure and maintenance of healing of all grades of erosive esophagitis, also known as erosive gastroesophageal reflux disease (GERD), as well as relief from associated heartburn, the company announced. Vonoprazan, an oral potassium-competitive acid …

Read more

FDA approves first Stelara biosimilar, Wezlana

FDA approves first Stelara biosimilar, Wezlana

Stelara is an interleukin-12 and interleukin-23 antagonist used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. The original product is available in intravenous and subcutaneous formulations. The FDA has approved Wezlana (ustekinumab-auub), making it the first approval for blockbuster biosimilar drug Stelara (ustekinumab). The agency also granted Wezlana an interchangeability …

Read more

FDA approves Vonoprazan to treat erosive esophagitis

FDA approves Vonoprazan to treat erosive esophagitis

The U.S. Food and Drug Administration (FDA) approved Phathom Pharmaceuticals’ vonoprazan (Voquenza) on November 1, 2023 for the treatment of adults with erosive esophagitis (erosive GERD), a gastroesophageal reflux disease. The drug is expected to be commercially available by December 2023. The drug’s approval marks a critical moment for more than 20 million patients suffering …

Read more

FDA approves secukinumab for adults with HS

FDA approves secukinumab for adults with HS

The U.S. Food and Drug Administration (FDA) has approved secukinumab for the treatment of adults with moderate to severe hidradenitis suppurativa (HS). This development, announced today, makes secukinumab the first and only interleukin (IL)-17A inhibitor approved by the FDA for the treatment of HS, which affects approximately 1% of the global population. It joins adalimumab, …

Read more

Yes, the FDA warns against using eye drops from multiple brands due to the risk of infection.

Yes, the FDA warns against using eye drops from multiple brands due to the risk of infection.

Many people use eye drops to treat certain eye problems, such as allergies, dryness, irritation, and redness. Recent online search trends show that some people are wondering whether the Food and Drug Administration (FDA) has issued a new warning regarding eye drops sold in the United States. THE QUESTION Is the FDA warning people to …

Read more

FDA takes first step to protect children from drugs that look and taste like candy

FDA takes first step to protect children from drugs that look and taste like candy

Is this gum a vitamin or a candy? This can be difficult to tell, especially for children. Since 2019, there has been an increase in the number of children under the age of 4 who have been taken to emergency rooms for ingesting gummy multivitamins and over-the-counter sleeping pills like melatonin. That’s why the Food …

Read more

FDA takes first step to protect children from drugs that look and taste like candy

FDA takes first step to protect children from drugs that look and taste like candy

Is this gum a vitamin or a candy? This can be difficult to tell, especially for children. Since 2019, there has been an increase in the number of children under the age of 4 who have been taken to emergency rooms for ingesting gummy multivitamins and over-the-counter sleeping pills like melatonin. That’s why the Food …

Read more

FDA warns against purchasing eye drops manufactured in ‘unsanitary conditions’

FDA warns against purchasing eye drops manufactured in 'unsanitary conditions'

The Food and Drug Administration on Monday expanded its warning not to buy or use eye drops sold by several major retailers, sometimes under their own brands. The warning now includes the product Equate Hydration PF Lubricant Eye Drop 10 mL sold by Walmart, the FDA said. “Walmart is removing the product from its store …

Read more

FDA Warns Consumers Against Using 26 Eye Drops Due to Risk of Infection

FDA Warns Consumers Against Using 26 Eye Drops Due to Risk of Infection

Federal regulators are warning consumers to stop using a number of over-the-counter eye drops that may pose an infection risk, marking the latest in a series of alerts this year. against artificial tears. The notice applies to 26 eye drop products marketed under several commercial brands, such as CVS Health, Rite Aid and Target Up …

Read more

FDA Approves New Corticosteroid Treatment Option for DMD Patients | BioSpace

FDA Approves New Corticosteroid Treatment Option for DMD Patients |  BioSpace

Pictured: A boy sitting in a wheelchair on a beach/iStock, ChiccoDodiFC The FDA on Thursday approved Santhera Pharmaceuticals’ new corticosteroid vamorolone, now marketed under the brand name Agamree, for the treatment of Duchenne muscular dystrophy. The announcement was made by Florida-based Catalyst Pharmaceuticals, which paid $90 million upfront in June 2023 and pledged up to …

Read more